Safety Events Common in Newly Approved Drugs

N/A by N/A is licensed under N/A N/A
Nearly one third of drugs newly approved by the US Food and Drug Administration (FDA) are affected by safety issues that were not known at the time of approval, a study has shown.

Biologic and psychiatric drugs, as well as those that received accelerated approval or were approved within 60 days of the statutory decision deadline, are the most vulnerable to postmarket safety events, Nicholas S. Downing, MD, from the Department of Medicine at Brigham and Women's Hospital in Boston, Massachusetts, and colleagues report. Their study was published online May 9 in JAMA.

The findings "are not surprising to those of us who have been following this for a while, but they do reflect a growing realization by the mainstream medical community that there are important differences between efficacy in randomized controlled trials and effectiveness once a drug hits the real world," Peter J. Pitts told Medscape Medical News. Pitts is a former FDA associate commissioner and current president of the Center for Medicine in the Public Interest, New York, New York. "It reinforces the basic truth that when you give people medicine, interesting things will happen — good and bad. Postmarket research is the continual search for understanding what these interesting things are in the real world," he added.


 
Article Photo Credit: N/A by N/A is licensed under N/A N/A
Sign Up for Our Email Newsletter

RECENT NEWS

Baby formula shortage: ‘There is light at the end of the tunnel,’ former FDA exec says

Baby formula shortage: ‘There is light at the end of the tunnel,’ former FDA exec says

Peter Pitts, president of the Center for Medicine in the Public Interest, joins Yahoo Finance Live to discuss the ongoing...  Read more

Former FDA official rips Biden over handling of baby formula shortage: 'Smoke and mirrors'

Former FDA official rips Biden over handling of baby formula shortage: 'Smoke and mirrors'

Peter Pitts, a former FDA associate commissioner, joined 'Fox & Friends First' to discuss the Biden administration's hand...  Read more

Peter Pitts speaks to CNN about baby formula shortage
  • CNN
  • 05/13/2022 12:00 AM

Peter Pitts speaks to CNN about baby formula shortage

Former FDA Associate Commissioner Peter Pitts speaks with CNN on the shortage of baby formula on May 13, 2022....  Read more

DRUGWONKS BLOG